Show simple item record

dc.contributor.authorBrierley, Marsha L.
dc.contributor.authorChater, Angel M.
dc.contributor.authorEdwardson, Charlotte L.
dc.contributor.authorCastle, Ellen M.
dc.contributor.authorHunt, Emily R.
dc.contributor.authorBiddle, Stuart JH.
dc.contributor.authorSisodia, Rupa
dc.contributor.authorBailey, Daniel P.
dc.date.accessioned2024-05-23T11:47:13Z
dc.date.available2024-05-23T11:47:13Z
dc.date.issued2024
dc.identifier.citationBrierley, M. L., Chater, A. M., Edwardson, C. L., Castle, E. M., Hunt, E. R., Biddle, S. J., Sisodia, R., & Bailey, D. P. (2024). The Regulate your Sitting Time (RESIT) intervention for reducing sitting time in individuals with type 2 diabetes : findings from a randomised-controlled feasibility trial. <i>Diabetology & Metabolic Syndrome</i>, <i>16</i>, Article 87. <a href="https://doi.org/10.1186/s13098-024-01336-6" target="_blank">https://doi.org/10.1186/s13098-024-01336-6</a>
dc.identifier.otherCONVID_213510017
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/95123
dc.description.abstractBackground Reducing and breaking up sitting is recommended for optimal management of Type 2 diabetes mellitus (T2DM). Yet, there is limited evidence of interventions targeting these outcomes in individuals with this condition. The primary aim of this study was to assess the feasibility and acceptability of delivering and evaluating a tailored online intervention to reduce and break up sitting in adults with T2DM. Methods A mixed-methods two-arm randomised controlled feasibility trial was conducted in ambulatory adults with T2DM who were randomised 1:1 to the REgulate your SItting Time (RESIT) intervention or usual care control group. The intervention included online education, self-monitoring and prompt tools (wearable devices, smartphone apps, computer apps) and health coaching. Feasibility outcomes were recruitment, attrition, data completion rates and intervention acceptability. Measurements of device-assessed sitting (intended primary outcome for definitive trial), standing and stepping, and physical function, psychosocial health and wellbeing were taken at baseline, 3 months and 6 months. Individual semi-structured interviews were conducted at six-months (post intervention) to explore acceptability, feasibility and experiences of the trial and intervention using the Framework Method. Results Seventy participants aged 55 ± 11 years were recruited. Recruitment rate (proportion of eligible participants enrolled into the study) was 67% and participant retention rate at 6 months was 93% (n = 5 withdrawals). Data completion rates for daily sitting were 100% at baseline and ranged from 83 to 91% at 3 months and 6 months. Descriptive analysis demonstrated potential for the intervention to reduce device-measured sitting, which was 30.9 ± 87.2 and 22.2 ± 82.5 min/day lower in the intervention group at 3 and 6 months, respectively, compared with baseline. In the control group, sitting was 4.4 ± 99.5 and 23.7 ± 85.2 min/day lower at 3 and 6 months, respectively. Qualitative analysis identified three themes: reasons for participating in the trial, acceptability of study procedures, and the delivery and experience of taking part in the RESIT intervention. Overall, the measurement visits and intervention were acceptable to participants. Conclusions This study demonstrated the feasibility and acceptability of the RESIT intervention and evaluation methods, supporting a future definitive trial. If RESIT is found to be clinically effective, this could lead to changes in diabetes healthcare with a focus on reducing sitting.en
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.ispartofseriesDiabetology & Metabolic Syndrome
dc.rightsCC BY 4.0
dc.subject.othersedentary behaviour
dc.subject.otherprolonged sitting
dc.subject.otherphysical activity
dc.subject.otherbehaviour change
dc.subject.otherdiabetes
dc.subject.otherActivPAL
dc.subject.othermixed methods
dc.titleThe Regulate your Sitting Time (RESIT) intervention for reducing sitting time in individuals with type 2 diabetes : findings from a randomised-controlled feasibility trial
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-202405233887
dc.contributor.laitosLiikuntatieteellinen tiedekuntafi
dc.contributor.laitosFaculty of Sport and Health Sciencesen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.description.reviewstatuspeerReviewed
dc.relation.issn1758-5996
dc.relation.volume16
dc.type.versionpublishedVersion
dc.rights.copyright© 2024 the Authors
dc.rights.accesslevelopenAccessfi
dc.subject.ysodiabetes
dc.subject.ysofyysinen aktiivisuus
dc.subject.ysoaikuistyypin diabetes
dc.subject.ysoistuminen
dc.subject.ysoliikkumattomuus
dc.subject.ysointerventio
dc.subject.ysosatunnaistetut vertailukokeet
dc.subject.ysokäyttäytymismallit
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p8304
jyx.subject.urihttp://www.yso.fi/onto/yso/p23102
jyx.subject.urihttp://www.yso.fi/onto/yso/p8303
jyx.subject.urihttp://www.yso.fi/onto/yso/p13022
jyx.subject.urihttp://www.yso.fi/onto/yso/p24012
jyx.subject.urihttp://www.yso.fi/onto/yso/p41
jyx.subject.urihttp://www.yso.fi/onto/yso/p38295
jyx.subject.urihttp://www.yso.fi/onto/yso/p2486
dc.rights.urlhttps://creativecommons.org/licenses/by/4.0/
dc.relation.dataset10.17633/rd.brunel.25144490
dc.relation.doi10.1186/s13098-024-01336-6
jyx.fundinginformationThis work was supported by Diabetes UK grant number [19/0005972].
dc.type.okmA1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

CC BY 4.0
Except where otherwise noted, this item's license is described as CC BY 4.0